| O2⋅− and H2O2-mediated disruption of Fe metabolism causes the differential susceptibility of NSCLC and GBM cancer cells to pharmacological ascorbate JD Schoenfeld, ZA Sibenaller, KA Mapuskar, BA Wagner, ... Cancer cell 31 (4), 487-500. e8, 2017 | 486 | 2017 |
| Cardiopulmonary resuscitation: outcome and its predictors among hospitalized adult patients in Pakistan NU Khan, JA Razzak, H Ahmed, M Furqan, AF Saleem, H Alam, A Huda, ... International journal of emergency medicine 1, 27-34, 2008 | 417* | 2008 |
| Lsst science book, version 2.0 PA Abell, J Allison, SF Anderson, JR Andrew, JRP Angel, L Armus, ... | 385 | 2009 |
| MEK and the inhibitors: from bench to bedside A Akinleye, M Furqan, N Mukhi, P Ravella, D Liu Journal of hematology & oncology 6, 1-11, 2013 | 352 | 2013 |
| Phosphatidylinositol 3-kinase (PI3K) inhibitors as cancer therapeutics A Akinleye, P Avvaru, M Furqan, Y Song, D Liu Journal of hematology & oncology 6, 1-17, 2013 | 333 | 2013 |
| Dysregulation of JAK-STAT pathway in hematological malignancies and JAK inhibitors for clinical application M Furqan, N Mukhi, B Lee, D Liu Biomarker research 1, 1-10, 2013 | 223 | 2013 |
| STAT inhibitors for cancer therapy M Furqan, A Akinleye, N Mukhi, V Mittal, Y Chen, D Liu Journal of hematology & oncology 6, 1-11, 2013 | 219 | 2013 |
| Novel ALK inhibitors in clinical use and development C Iragavarapu, M Mustafa, A Akinleye, M Furqan, V Mittal, S Cang, D Liu Journal of Hematology & Oncology 8, 1-9, 2015 | 104 | 2015 |
| The clinical significance of soluble PD-1 and PD-L1 in lung cancer TA Hejleh, M Furqan, Z Ballas, G Clamon Critical reviews in oncology/hematology 143, 148-152, 2019 | 82 | 2019 |
| Lymph-node-targeted, mKRAS-specific amphiphile vaccine in pancreatic and colorectal cancer: the phase 1 AMPLIFY-201 trial S Pant, ZA Wainberg, CD Weekes, M Furqan, PM Kasi, CE Devoe, ... Nature medicine 30 (2), 531-542, 2024 | 80 | 2024 |
| Simulated LSST Survey of RR Lyrae Stars throughout the Local Group HM Oluseyi, AC BECkER, C Culliton, M Furqan, KL Hoadley, P Regencia, ... The Astronomical Journal 144 (1), 9, 2012 | 50 | 2012 |
| SBRT to adrenal metastases provides high local control with minimal toxicity K Plichta | 43* | |
| Venoarterial PCO2 difference: a marker of postoperative cardiac output in children with congenital heart disease M Furqan, F Hashmat, M Amanullah, M Khan, HK Durani, A Haque Journal of the College of Physicians and Surgeons Pakistan 19 (10), 640, 2009 | 42 | 2009 |
| Drug overdose: a wake up call! Experience at a tertiary care centre in Karachi, Pakistan MJ Patel, M Shahid, M Riaz, W Kashif, SI Ayaz, MS Khan, AJ Samdani, ... Journal of the Pakistan Medical Association 58 (6), 298, 2008 | 41 | 2008 |
| Mitochondrial superoxide increases age-associated susceptibility of human dermal fibroblasts to radiation and chemotherapy KA Mapuskar, KH Flippo, JD Schoenfeld, DP Riley, S Strack, TA Hejleh, ... Cancer research 77 (18), 5054-5067, 2017 | 39 | 2017 |
| Surface area in children: a simple formula M Furqan, A Haque Indian Pediatr 46 (12), 1085-1087, 2009 | 37 | 2009 |
| Novel agents for advanced pancreatic cancer A Akinleye, C Iragavarapu, M Furqan, S Cang, D Liu Oncotarget 6 (37), 39521, 2015 | 32 | 2015 |
| Phase Ib study of eprenetapopt (APR-246) in combination with pembrolizumab in patients with advanced or metastatic solid tumors H Park, GI Shapiro, X Gao, A Mahipal, J Starr, M Furqan, P Singh, ... ESMO open 7 (5), 100573, 2022 | 30 | 2022 |
| Pharmacological ascorbate improves the response to platinum-based chemotherapy in advanced stage non-small cell lung cancer M Furqan, T Abu-Hejleh, LM Stephens, SM Hartwig, SL Mott, CF Pulliam, ... Redox biology 53, 102318, 2022 | 27 | 2022 |
| Global variation in anastomosis and end colostomy formation following left-sided colorectal resection GlobalSurg Collaborative, ... BJS open 3 (3), 403-414, 2019 | 25 | 2019 |
